Fraser Hall

President, Head of Intercontinental Region · Biogen

Biotechnology

Fraser Hall leads Biogen’s Intercontinental Region after regional and global pharmaceutical leadership roles at AstraZeneca and Novartis.

Last reviewed: Nov 2, 2026

Fraser Hall

President, Head of Intercontinental Region
Biogen

Last Reviewed: November 2, 2026

Executive Summary

Fraser Hall leads Biogen’s Intercontinental Region after regional and global pharmaceutical leadership roles at AstraZeneca and Novartis.

Career Highlights

  • Joined Biogen in July 2020 as vice president for Latin America.
  • Previously became president of AstraZeneca Brazil in September 2016.
  • Spent 13 years at Novartis in country, regional and global roles.

Professional Journey

Hall spent 13 years at Novartis, with leadership and general management responsibilities at country, regional and global levels. His assignments included substantial work in Asia and developing markets.

He moved to AstraZeneca in 2015. His first assignment there was in the global organization, where he led strategy and launch preparation for a new stroke treatment. In September 2016, he became president of AstraZeneca Brazil.

As country president, Hall’s work included the Brazilian COVID clinical trial program and negotiations with the government over vaccine supply. In a 2017 interview, he described the move from global launch preparation to country leadership and opportunities to partner with state and federal government to broaden access to treatment.

Hall joined Biogen in July 2020 as vice president for Latin America. He now serves as president and head of the Intercontinental Region, covering Latin America, Australia, Asia, Japan, the Middle East and Africa, Turkey and Russia/CIS.

Education

Hall earned a B.Sc. from Aston University. He also completed finance and organizational leadership courses at Harvard and MIT.